Barclays PLC Has $2.19 Million Stock Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
Barclays PLC raised its position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 11.2% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 243,948 shares of the biotechnology company’s stock after purchasing an additional 24,617 shares during the quarter. Barclays PLC’s holdings in Aurinia Pharmaceuticals were worth $2,190,000 at the end […]
